Renal Outcomes Associated with Direct Acting Antiviral Therapy in Patients with Hepatitis C Virus Infection

被引：0
|
作者：
Thomas, Fridtjof [1 ]
Potukuchi, Praveen Kumar [1 ]
Dashputre, Ankur A. [1 ]
Sumida, Keiichi [1 ]
Molnar, Miklos Z. [2 ]
Streja, Elani [3 ]
Kalantar-Zadeh, Kamyar [3 ]
Kovesdy, Csaba P. [1 ,4 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[2] Univ Utah Hlth, Salt Lake City, UT USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] VA Memphis Med Ctr, Memphis, TN USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-OR55
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] Oral direct-acting antiviral therapy for hepatitis C virus infection in X-linked agammaglobulinemia
    Wolf, Hermann M.
    Eibl, Martha M.
    Mueller, Christian J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (03): : 1049 - 1051
  • [42] A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
    Mazzaro, Cesare
    Quartuccio, Luca
    Adinolfi, Luigi Elio
    Roccatello, Dario
    Pozzato, Gabriele
    Nevola, Riccardo
    Tonizzo, Maurizio
    Gitto, Stefano
    Andreone, Pietro
    Gattei, Valter
    VIRUSES-BASEL, 2021, 13 (11):
  • [43] Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection
    Sugimoto, Ryosuke
    Iwasa, Motoh
    Hara, Nagisa
    Tamai, Yasuyuki
    Yoshikawa, Kyoko
    Ogura, Suguru
    Tanaka, Hideaki
    Eguchi, Akiko
    Yamamoto, Norihiko
    Kobayashi, Yoshinao
    Hasegawa, Hiroshi
    Takei, Yoshiyuki
    HEPATOLOGY RESEARCH, 2018, 48 (05) : 337 - 344
  • [44] Demographic Predictors of Direct Acting Antiviral Receipt in Individuals with Hepatitis C Virus Infection
    Kanwal, Fasiha
    Kramer, Jennifer R.
    Cao, Yumei
    Taylor, Thom
    Smith, Donna
    Asch, Steven
    El-Serag, Hashem B.
    HEPATOLOGY, 2015, 62 : 722A - 722A
  • [45] What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou, George N.
    Feld, Jordan J.
    GASTROENTEROLOGY, 2019, 156 (02) : 446 - +
  • [46] CHANGING POPULATION OF LIVER TRANSPLANT RECIPIENTS IN THE ERA OF DIRECT ACTING ANTIVIRAL THERAPY FOR HEPATITIS C VIRUS INFECTION
    Xie, Chencheng
    Abdallah, Mohamed
    Wong, Robert J.
    Kwo, Paul Yien
    Thuluvath, Paul
    Asrani, Sumeet K.
    Singal, Ashwani K.
    HEPATOLOGY, 2019, 70 : 679A - 679A
  • [47] Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nakamura, Masato
    Jiang, Xia
    Miyamura, Tatsuo
    Wu, Shuang
    Yokosuka, Osamu
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (01) : 1 - 6
  • [48] FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection
    Trujillo, Sophie
    Ghoneim, Sara
    Butt, Muhammad
    Asaad, Imad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S509 - S510
  • [49] Direct-Acting Antiviral Treatment Failures and Resistance Associated Substitutions in Hepatitis C Virus Infection in Ireland
    Kelly, Abbie
    Dean, Jonathan
    O'Leary, Aisling
    Stewart, Stephen
    Feeney, Eoin
    Kelleher, Barry
    McKiernan, Susan Mary
    McCormick, P. Aiden
    Murray, Frank E.
    Crosbie, Orla M.
    Houlihan, Diarmuid
    Bergin, Colm
    Fanning, Liam J.
    Norris, Suzanne
    Lambert, Jack
    McConkey, Sam
    Courtney, Garry
    Lee, John
    De Gascun, Cillian
    HEPATOLOGY, 2018, 68 : 406A - 407A
  • [50] Persistent Hepatitis C Virus-Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy
    Santoriello, Dominick
    Pullela, Nanda K.
    Uday, Kalpana A.
    Dhupar, Shawn
    Radhakrishnan, Jai
    D'Agati, Vivette D.
    Markowitz, Glen S.
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (04): : 985 - 990
12345